-
Asia’s Biggest Vaccine Maker to Seek Fast-Track Nod for Dengue Drug in India
Asia's largest vaccine maker, Serum Institute of India, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
- Categories
- Health Care
- Region
- South Asia
-
Rural Children in India Have Better Immunization Rates
Contrary to earlier studies, children in rural India have higher vaccinationrates than those in cities and Hindu kids are more likely to get their shots than Muslims, researchers from a leading American university have said.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Ebola’s ‘magic pill’ might actually be a machine
Early intervention with medical devices focused on “simple things” could be better than drugs at halting infectious disease outbreaks.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
5 dengue vaccines in development
Currently, there are no approved vaccines or therapies to prevent dengue infection. The disease, which primarily affects children, is associated with approximately 22,000 deaths annually worldwide, according to the CDC. Infectious Disease News has compiled information on five candidate dengue vaccines in various stages of development.
- Categories
- Health Care
-
Zimbabwe Running Out of BCG Vaccine
Zimbabwe is running short of BCG vaccine meant to protect newborn babies from contracting tuberculosis (TB) — one of the six infant killer diseases.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
OPINION: (Chelsea Clinton) The lurking threat to child survival
Emergency infectious disease outbreaks like Ebola and MERS, as serious as they are, have become black holes, sucking the necessary ingredients from health systems that could be allocated toward saving babies.
- Categories
- Health Care
- Tags
- vaccines
-
Vaccine Reminder Company Tested in Developing World
A Cornellian’s nonprofit that helps parents in developing countries remember their children’s vaccination dates with bracelets has completed an initial study in Peru and Ecuador and is moving into trials and evaluations in three countries on three continents.
- Categories
- Health Care
- Region
- Latin America
-
Viewpoint: The Ebola Vaccine We Needed
About 27,000 people in West Africa have been infected with the Ebola virus and more than 11,000 of them have died since the outbreak began last year. Many could have been saved if an effective vaccine had been available. But the world relies on drug companies to create new vaccines and medications, and they have no financial incentive to do so for diseases that mostly affect poor countries. Clearly, the world needs a better mechanism for vaccine development.
- Categories
- Health Care
- Region
- Sub-Saharan Africa